According to a report, “Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis By Type (Complement System Proteins, Free Light Chain, Haptoglobin, Immunoglobulin), By Technology, By Application, And Segment Forecasts, 2018 – 2025”, published by Grand View Research, Inc. The global immunoprotein diagnostic testing market size is expected to reach USD 10.3 billion by 2025, registering a staggering CAGR, as per a new report by Grand View Research Inc. The market demand can be attributed to the rising incidence of chronic diseases.
According to a 2017 research report by the American Heart Association, nearly 790,000 people suffer heart attack every year in the U.S. Furthermore, stroke is responsible for 1 in every 20 deaths in the country. Hence, WHO is undertaking initiatives to decrease the risk and occurrence of cardiovascular diseases. Such factors are driving the demand for immunoprotein diagnostics and are expected to rise during the forecast period in order to facilitate rapid diagnosis.
According to WHO, nearly 1.69 million deaths were registered due to lung cancer in 2015, worldwide. As a result, fast and accurate diagnosis of chronic diseases has become crucial to reduce the growing mortality rate. Immunoprotein diagnostic devices and reagents have proven to be highly effective in detecting chronic diseases.
Technological advancements in immunoprotein diagnostics have led to the introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.
Immunoprotein Diagnostic Testing Market Highlights
Immunoglobulin tests held the test type segment in 2016 due to its widespread adoption by healthcare professionals to monitor the functioning of a patient’s immune system in autoimmune or infectious diseases.
C-Reactive Protein (CRP) tests are gaining huge traction as they can assist in monitoring the treatment effectiveness for infectious diseases and cancer. CPR tests also accounted for a significant market share in 2016.
On the basis of application, infectious disease testing led the market in 2016, followed by oncology testing. Infectious disease testing segment growth can be ascribed to the rising prevalence of chronic infectious diseases, such as HIV/AIDS. Enzyme-based immunoassays are gaining popularity as they are considered rapid testing techniques for disease identification.
Enzyme-based Immunoassay (EIA) led the market, accounting for the largest revenue share in 2016. Human Complement C3 ELISA Kit developed by Abcam uses EIA technology for diagnosis.
“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/immunoprotein-diagnostic-testing-industry/request/rs1
Immunoprotein Diagnostic Testing Market Segmentation
Grand View Research has segmented the immunoprotein diagnostic testing market on the basis of test type, application, technology, and region:
Immunoprotein Diagnostic Testing Test Type Outlook (Revenue, USD Million, 2014 – 2025)
Complement System Proteins Diagnostic Tests
Free Light Chain Diagnostic Tests
Haptoglobin Diagnostic Tests
Immunoglobulin Diagnostic Tests
Prealbumin Diagnostic Tests
C-Reactive Protein (CRP) Diagnostic Tests
Immunoprotein Diagnostic Testing Application Outlook (Revenue, USD Million, 2014 – 2025)
Infectious Disease Testing
Autoimmune Disease Testing
Immunoprotein Diagnostic Testing Technology Outlook (Revenue, USD Million, 2014 – 2025)
Immunoprotein Diagnostic Testing Regional Outlook (Revenue, USD Million, 2014 – 2025)
List of Key Players in Immunoprotein Diagnostic Testing Market
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche AG
Enzo Biochem, Inc.
Thermo Fisher Scientific, Inc.
Siemens Healthcare GmbH
Have Any Query? Ask Our Experts for More Details on Report:https://www.grandviewresearch.com/inquiry/172/ibb
Browse Related Report @
Large Molecule Bioanalytical Testing Service Market – https://www.grandviewresearch.com/industry-analysis/large-molecule-bioanalytical-testing-service-market
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
Country: United States